The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nanobody-based PET/CT imaging of HER2 expression in breast carcinoma: Phase I results and potential to assess tumor heterogeneity.
 
Marleen Keyaerts
Patents, Royalties, Other Intellectual Property - Vrije Universiteit Brussel (Inst)
 
Catarina Xavier
No Relationships to Disclose
 
Johannes Heemskerk
No Relationships to Disclose
 
Nick Devoogdt
Leadership - Camel-IDS
Stock and Other Ownership Interests - Camel-IDS
Research Funding - Boehringer Ingelheim; Complix
Patents, Royalties, Other Intellectual Property - VUB patents on Nanobody imaging and therapy
 
Hendrik Everaert
No Relationships to Disclose
 
Thierry Gevaert
No Relationships to Disclose
 
Marian Vanhoeij
No Relationships to Disclose
 
Francois P. Duhoux
Honoraria - Roche Pharma AG; Teva
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Teva (Inst)
Travel, Accommodations, Expenses - Amgen; Roche Pharma AG
 
Philippe Simon
No Relationships to Disclose
 
Denis C. C. Schallier
No Relationships to Disclose
 
Christel Fontaine
No Relationships to Disclose
 
Ilse Vaneycken
No Relationships to Disclose
 
Chris Vanhove
No Relationships to Disclose
 
Jacques De Greve
No Relationships to Disclose
 
Jan Lamote
No Relationships to Disclose
 
Vicky Caveliers
No Relationships to Disclose
 
Tony Lahoutte
Leadership - Camel-IDS
Stock and Other Ownership Interests - Camel-IDS
Consulting or Advisory Role - National Institute for Radioelements (IRE)
Research Funding - Boehringer Ingelheim; Complix
Patents, Royalties, Other Intellectual Property - VUB patents on Nanobody imaging and therapy
Travel, Accommodations, Expenses - Bayer Schering Pharma